Award
National Cancer Institute 1R01CA316114-01
Advancing NEMO’s specific MRI detection of residual breast cancer using novel imaging platforms
Recipient
West Virginia University, Morgantown, WV, United States
Award Amount
$484,944.00
Ceiling
$484,944.00
Awarded
June 05, 2026
Identifier
1R01CA316114-01
Development of Nano-Encapsulated Manganese Oxide (NEMO) particles as a tumor-specific MRI contrast agent to improve detection of residual breast cancer after chemotherapy, enabling more breast-conserving surgeries.
Description
This project aims to develop and validate a novel MRI contrast agent (NEMO particles) targeted to breast cancer cells, with the goal of improving detection of residual disease post-therapy and enabling more breast-conserving surgeries. It involves advanced microfluidic MRI testing, in vivo mouse models, and innovative imaging platforms.